Treatment of Vasospastic Amaurosis Fugax with Calcium-Channel Blockers

  • Winterkorn J
  • Kupersmith M
  • Wirtschafter J
  • et al.
131Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Amaurosis fugax, a brief loss of vision in one eye, is caused by hypoperfusion of the retinal circulation. If an attack of amaurosis is prolonged, the patient is at risk of permanent visual loss. Since the 1950s, amaurosis fugax has usually been attributed to embolism from the heart or great vessels1 or to carotid occlusive disease. Because of the difficulty in differentiating between these and other causes, amaurosis fugax remains a therapeutic challenge. Depending on the patency of the internal carotid arteries, the principal treatments are anticoagulation or antiplatelet therapy2 and carotid endarterectomy3. Vasospasm is rarely reported as a . . .

Cite

CITATION STYLE

APA

Winterkorn, J., Kupersmith, M. J., Wirtschafter, J. D., & Forman, S. (1993). Treatment of Vasospastic Amaurosis Fugax with Calcium-Channel Blockers. New England Journal of Medicine, 329(6), 396–398. https://doi.org/10.1056/nejm199308053290604

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free